NanoDimension

Aymeric is an elected member of the World Economic Forum’s “Young Global Leaders” Class of 2013 and the Swiss Academy of Engineering Sciences (2016) He received the “2007 NSTI Fellow Award” and “2012 EPFL Alumni” award

Aymeric holds a Masters in Physical Engineering from EPFL where he is still an active member of the SAB and Chairman of the alumni association

Patrick joined +ND Capital in our Lausanne office in 2017 He is currently a board member of Amazentis, Vandria and a former board member of Arctos Medical (sold to Novartis)

Prior to this, he was President of the Swiss Federal Institute of Technology (EPFL) for 16 years, which was transformed into a world-class science and technology university under his leadership He has co-founded three biotechnology companies, and currently sits on the board of Nestlé and Logitech He chairs the advisory board of the Novartis Venture Fund and continues to serve as an advisor to a number of private companies He is also a former board member of Lonza

Patrick was trained as an MD and Neuroscientist at the University of Geneva and Fribourg in Switzerland He has been a Professor at Brown University and the Lausanne University Hospital (CHUV), where he focused on cell and gene therapy approaches for the treatment of neurodegenerative diseases He is a fellow of the American Institute for Medical and Biological Engineering and the Swiss Academy of Medical Sciences

Dani joined +ND Capital in our Lausanne office in 2019 He is currently a board member of  Cytoki, EVIR Therapeutics, Vandria, Osasuna Therapeutics and a board observer of Amazentis He is also a former board member of Arctos Medical (sold to Novartis) and CellPoint (sold to Galapagos)

Prior to this, Dani spent 12 years as a venture capital investor in the life sciences and 10 years in academic research Dani’s motivation has been to translate scientific innovation into better healthcare He is passionate about working with entrepreneurs to develop better medicines and cures Prior to joining +ND Capital, Dani served on the board of 15 companies in Europe and the US, ranging from drug development to medical devices and digital health Some of these companies have developed viruses capable of curing cancer, engineered proteins to tackle rare diseases and invented devices to keep heart failure patients safe Dani became a venture capital investor at Index Ventures (Geneva), to join later Aravis Ventures (Zurich) and Imperial Innovations – IP Group (London) During his previous life as a scientist at the University of Geneva and at the Swiss Federal Institute of Technology (EPFL)  in Lausanne, Dani conducted research in immunology and virology (HIV)

Dani holds a PhD in molecular biology from the University of Barcelona and an executive MBA from EOI Business School (Madrid)

Eric joined +ND Capital in 2008 and was the first employee of our Silicon Valley office He is focused on life sciences investments Eric is currently a board member of Emulate, Visby Medical, Serotiny, Lightcast, AIRNA and a board observer of IonPath and Inscripta He was previously a board member of Icosavax (Nasdaq: ICVX) and SQZ Biotech (NYSE: SQZ), and observed on the boards of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST) Eric also helped lead +ND Capital’s investments in Orca, Octant and Nutcracker

Before joining +ND Capital, Eric was a consultant at Bain & Company in Zurich and San Francisco While at Bain, Eric worked on strategy cases in healthcare, industrial goods and telecommunications and on the turn-around of an electrical component manufacturer In addition, Eric spent eight months in Bain’s Private Equity Group

Eric has an MSc from the London School of Economics and a BS/BA from the University of Florida

Kirill joined +ND Capital in our Silicon Valley office in 2013 He is focused on physical science investments and is currently a board observer of SiMa ai and Spark Microsystems

Prior to this, he worked with Rusnano, a Russian nanotechnology initiative, where he sourced, structured, and managed nanotech-related deals starting in 2009 Before Rusnano, Kirill worked for four years at a Russian private equity fund and was in charge of several investments in logistics, pharmaceuticals, and technology Kirill also worked in various positions as an engineer, consultant (Boston Consulting Group), and operational manager in Korea, U S , U K , and Russia

Kirill holds a Masters in Computer Science from the Electrotechnical University of St Petersburg as well as an MBA from INSEAD, France

Chief Operating Officer & Chief Financial Officer Peter joined +ND Capital in our Silicon Valley office in 2019 He has 25 years of experience as an investment executive including listed equities, private equity, and venture capital in the USA, UK, Europe, Asia, and South Africa His sector experience includes Technology, Life Sciences, Physical Sciences, Consumer, Property, and Infrastructure He has been on the board and sub-committees of 15 companies ranging from early-stage to a FTSE 100 company He is currently a board observer of Natron Energy

Peter’s original work experience was in South Africa where he qualified as a Chartered Accountant in 1994 and is a member of the South African Institute of Chartered Accountants He completed an Advanced Management Program at Harvard Business School in 2013

Executive Director of the General Partner Jonathan joined +ND Capital in 2005 and is based in our Grand Cayman office He is the former Managing Director of Merrill Lynch Bank & Trust Company and Head of Corporate Management at KPMG in the Cayman Islands He has an extensive background as a director of several important and sizeable investment entities

Jonathan is a Fellow of the Institute of Chartered Accountants in England and Wales

2983 Woodside Road Woodside, CA 94062 tel: +1 650 241 1155 email: info@nd capital

• EPFL Innovation Park Building F – 1st Floor CH-1015 Lausanne Switzerland tel: +41 21 561 33 00 email: info@nd capital Governor’s Square, Unit 3-113B P O Box 526 WB 23, Lime Tree Bay Ave Grand Cayman, KY1-1302 Cayman Islands tel: +1 345 516 0210 email: info@nd capital